RCGP Secure Environments Group. (2011) Safer prescribing in prisons: guidance for clinicians. London: Royal College of General Practitioners.
Preview | Title | Contact |
---|---|---|
|
PDF (Safer prescribing in prisons: Guidance for clinicians)
- Published Version
427kB |
Endorsed by the Royal Pharmaceutical Society, the guidance is the first of its kind to address this often challenging area. It looks at a number of clinical areas and highlights issues such as medication misuse by patients and medications being traded between inmates.
This guidance has been written to assist clinicians working in prisons but it also has relevance for clinicians working in other secure environments such as forensic physicians and custody nurses; consultant psychiatrists; pain clinic prescribers; hospital prescribers and general practitioners who work with offenders.
Dr Marcus Bicknell, Chair of the Secure Environments Group, said:
"There are 136 prisons in England and approximately 250,000 people move through the prison system each year, many of whom will have health issues and need care. We hope this guidance will prove helpful to the different healthcare teams who have a responsibility to work with patients in secure settings."
Areas covered by the guidance include:
■Possession of Medicines
■Pain
■Neuropathic Pain
■Depression
■Epilepsy and Other Convulsive Conditions
■Psychoses
■Attention Deficit Hyperactivity Disorder (ADHD)
■Benzodiazepines: Use in Anxiety and Other Related Disorders
■Insomnia
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Prison-based health service
MM-MO Crime and law > Justice system > Correctional system and facility > Prison
HJ Treatment or recovery method > Substance disorder treatment method
VA Geographic area > Europe > United Kingdom
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
T Demographic characteristics > Prison Inmate (prisoner)
Repository Staff Only: item control page